Anna Marie Wager

SVP of Corporate Development, Ginkgo Bioworks

Anna Marie Wagner, MBA, is the SVP of Corporate Development and Interim CFO for Ginkgo Bioworks. Ginkgo is a synthetic biology company that genetically engineers "made-to-order" microbes for customers across industries, including industrial chemicals, pharmaceuticals, food and agriculture, and personal care. Ginkgo designs these microbes in a 100K+ sqft Boston facility that brings scale economics to biological engineering using robotic automation and custom software. The company has raised over $800M in venture capital funding and has partnerships with companies including Bayer, ADM, Cargill, Genomatica, Cronos, Roche, Synlogic, and Moderna.